SEARCH

SEARCH BY CITATION

References

  • Andreasen N., Hesse C., Davidsson P., Minthon L., Wallin A., Winblad B., Vanderstichele H., Vanmechelen E. and Blennow K. (1999) Cerebrospinal fluid {beta}-amyloid (1-42) in Alzheimer disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease. Arch. Neurol. 56, 673680.
  • Armstrong-James M. and Millar J. (1979) Carbon fibre microelectrodes. J. Neurosci. Methods 1, 279287.
  • Bibl M., Mollenhauer B., Lewczuk P. et al. (2007) Validation of amyloid-[beta] peptides in CSF diagnosis of neurodegenerative dementias. Mol. Psychiatry 12, 671680.
  • Blennow K. (2004) Cerebrospinal fluid protein biomarkers for Alzheimer’s disease. NeuroRx 1, 213225.
  • Brunelle P. and Rauk A. (2004) One-electron oxidation of methionine in peptide environments: the effect of three-electron bonding on the reduction potential of the radical cation. J. Phys. Chem. A 108, 1103211041.
  • Chikae M., Fukuda T., Kerman K., Idegami K., Miura Y. and Tamiya E. (2008) Amyloid-[beta] detection with saccharide immobilized gold nanoparticle on carbon electrode. Bioelectrochemistry 74, 118123.
  • Cirrito J. R., Yamada K. A., Finn M. B., Sloviter R. S., Bales K. R., May P. C., Schoepp D. D., Paul S. M., Mennerick S. and Holtzman D. M. (2005) Synaptic activity regulates interstitial fluid amyloid-[beta] levels in vivo. Neuron 48, 913922.
  • Cirrito J. R., Kang J. E., Lee J., Stewart F. R., Verges D. K., Silverio L. M., Bu G., Mennerick S. and Holtzman D. M. (2008) Endocytosis is required for synaptic activity-dependent release of amyloid-[beta] in vivo. Neuron 58, 4251.
  • Frederix F., Bonroy K., Reekmans G., Laureyn W., Campitelli A., Abramov M. A., Dehaen W. and Maes G. (2004) Reduced nonspecific adsorption on covalently immobilized protein surfaces using poly (ethylene oxide) containing blocking agents. J. Biochem. Biophys. Methods 58, 6774.
  • Halim A., Brinkmalm G., Rüetschi U., Westman-Brinkmalm A., Portelius E., Zetterberg H., Blennow K., Larson G. and Nilsson J. (2011) Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid. Proc. Natl. Acad. Sci. USA 108, 1184811853.
  • Hampel H., Frank R., Broich K., Teipel S. J., Katz R. G., Hardy J., Herholz K., Bokde A. L. W., Jessen F. and Hoessler Y. C. (2010) Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat. Rev. Drug Discov. 9, 560574.
  • Hardy J. A. and Higgins G. A. (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256, 184185.
  • Hebert L. E., Scherr P. A., Bienias J. L., Bennett D. A. and Evans D. A. (2003) Alzheimer disease in the US population. Arch. Neurol. 60, 11191122.
  • Huffman M. L. and Venton B. J. (2008) Carbon-fiber microelectrodes for in vivo applications. Analyst 134, 1824.
  • Kakiuchi T., Usui H., Hobara D. and Yamamoto M. (2002) Voltammetric properties of the reductive desorption of alkanethiol self-assembled monolayers from a metal surface. Langmuir 18, 52315238.
  • Kerman K., Nagatani N., Chikae M., Yuhi T., Takamura Y. and Tamiya E. (2006) Label-free electrochemical immunoassay for the detection of human chorionic gonadotropin hormone. Anal. Chem. 78, 56125616.
  • Kerman K., Vestergaard M., Chikae M., Yamamura S. and Tamiya E. (2007) Label-free electrochemical detection of the phosphorylated and non-phosphorylated forms of peptides based on tyrosine oxidation. Electrochem. Commun. 9, 976980.
  • Murphy M. P. and LeVine H. (2010) Alzheimer’s disease and the amyloid-beta peptide. J. Alzheimers Dis. 19, 311323.
  • Okuno J., Maehashi K., Kerman K., Takamura Y., Matsumoto K. and Tamiya E. (2007) Label-free immunosensor for prostate-specific antigen based on single-walled carbon nanotube array-modified microelectrodes. Biosens. Bioelectron. 22, 23772381.
  • Pantano P. and Kuhr W. G. (1991) Characterization of the chemical architecture of carbon-fiber microelectrodes. 1. Carboxylates. Anal. Chem. 63, 14131418.
  • Prabhulkar S. and Li C. Z. (2010) Assessment of oxidative DNA damage and repair at single cellular level via real-time monitoring of 8-OHdG biomarker. Biosens. Bioelectron. 26, 17431749.
  • Schöneich C., Pogocki D., Hug G. L. and Bobrowski K. (2003) Free radical reactions of methionine in peptides: mechanisms relevant to beta-amyloid oxidation and alzheimer’s disease. J. Am. Chem. Soc. 125, 1370013713.
  • Tampellini D. and Gouras G. K. (2010) Synapses, synaptic activity and intraneuronal A in Alzheimer’s disease. Front. Aging Neurosci. 2, pii-13.
  • Verges D., Restivo J., Goebel W., Holtzman D. and Cirrito J. (2011) Opposing synaptic regulation of amyloid-β metabolism by NMDA receptors in vivo. J. Neurosci. 31, 1132811337.
  • Vestergaard M., Kerman K., Saito M., Nagatani N., Takamura Y. and Tamiya E. (2005) A rapid label-free electrochemical detection and kinetic study of Alzheimer’s amyloid beta aggregation. J. Am. Chem. Soc. 127, 1189211893.
  • Wei F., Patel P., Liao W., Chaudhry K., Zhang L., Arellano-Garcia M., Hu S., Elashoff D., Zhou H. and Shukla S. (2009) Electrochemical sensor for multiplex biomarkers detection. Clin. Cancer Res. 15, 44464452.
  • Wyss-Coray T., Loike J. D., Brionne T. C., Lu E., Anankov R., Yan F., Silverstein S. C. and Husemann J. (2003) Adult mouse astrocytes degrade amyloid- in vitro and in situ. Nat. Med. 9, 453457.
  • Zhang S., Yang J. and Lin J. (2008) 3,3′-Diaminobenzidine (DAB)-H2O2-HRP voltammetric enzyme-linked immunoassay for the detection of carcionembryonic antigen. Bioelectrochemistry 72, 4752.